November 18, 2013 — Valencell and Iriver were both included in the “Ears Follow Eyes as Target in $1.84 Billion Wearable Boom” article in Bloomberg Businessweek. Read More
- Valencell Announces Medical Advisory Board Founding Members
- Managing hypertension will change more in next 5 years than the last 100 years
- What is cumulative blood pressure and why does it matter?
- Will wearables ever accurately measure blood pressure?
- Valencell’s Cuffless, Calibration-Free Blood Pressure Monitoring Technology Selected to Present at American College of Cardiology Annual Scientific Session